{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:59:09Z","timestamp":1777417149592,"version":"3.51.4"},"reference-count":152,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.addr.2009.11.025","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T04:47:57Z","timestamp":1259038077000},"page":"576-588","source":"Crossref","is-referenced-by-count":60,"title":["Nanotechnological approaches against Chagas disease"],"prefix":"10.1016","volume":"62","author":[{"given":"Eder Lilia","family":"Romero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2009.11.025_bib1","unstructured":"Organizacion Panamericana de la Salud, Estimacion cuantitativa de la enfermedad de Chagas en las Americas, Montevideo, Uruguay, OPS\/HDM\/CD\/425 (2006)."},{"key":"10.1016\/j.addr.2009.11.025_bib2","series-title":"Changing History","article-title":"The World Health Organization report 2004","year":"2004"},{"key":"10.1016\/j.addr.2009.11.025_bib3","series-title":"Chagas disease: a Latin American nemesis","author":"Strosberg","year":"2007"},{"key":"10.1016\/j.addr.2009.11.025_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0169-4758(00)01815-9","article-title":"Reaching maturity-25 years of the TDR","volume":"16","author":"Morel","year":"2000","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.addr.2009.11.025_bib5","series-title":"Tropical Disease Research: Progress 1995-1996","article-title":"Chagas Disease","year":"1997"},{"key":"10.1016\/j.addr.2009.11.025_bib6","first-page":"49","article-title":"Analise de manisfestacoes colaterais devidas ao uso do medicamento Ro-7-1051 nitromidazolico especico da doenca de Chagas","volume":"17","author":"Levi","year":"1975","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.addr.2009.11.025_bib7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(96)04128-1","article-title":"Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection","volume":"348","author":"de Andrade","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2009.11.025_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4269\/ajtmh.1998.59.526","article-title":"Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease","volume":"59","author":"Sosa Estani","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2009.11.025_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/S0074-02761999000700064","article-title":"Criteria of Chagas disease cure","volume":"94","author":"Can\u00e7ado","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.025_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S0074-02761999000700070","article-title":"Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines in Argentina","volume":"94","author":"Sosa Estani","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.025_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-6851(98)00037-1","article-title":"Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox","volume":"93","author":"Murta","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.addr.2009.11.025_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pt.2003.09.001","article-title":"Specific Chemotherapy of Chagas disease: controversies and advances","volume":"19","author":"Urbina","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.addr.2009.11.025_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova trypanozomiase humana: estudos sobre morfolog\u00eda e o ciclo evolutivo do Schizotrypanum cruzi","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.025_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2008.12.197","article-title":"Justice where justice is due: A posthumous Nobel Prize to Carlos Chagas (1879-1934), the discoverer of American Trypanosomiasis (Chagas\u00b4disease)","volume":"134","author":"Bestetti","year":"2009","journal-title":"Int. J. Cardiology"},{"key":"10.1016\/j.addr.2009.11.025_bib15","unstructured":"DNDi."},{"key":"10.1016\/j.addr.2009.11.025_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(07)61301-4","article-title":"Neglected diseases, civil conflicts, and the right to health","volume":"370","author":"Beyrer","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2009.11.025_bib17","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2009.11.025_bib18","unstructured":"http:\/\/www.dndi.org."},{"key":"10.1016\/j.addr.2009.11.025_bib19","unstructured":"http:\/\/www.mmv.org\/pages\/page_main.htm."},{"key":"10.1016\/j.addr.2009.11.025_bib20","unstructured":"http:\/\/www.oneworldhealth.org."},{"key":"10.1016\/j.addr.2009.11.025_bib21","unstructured":"http:\/\/www.who.int\/tdr\/."},{"key":"10.1016\/j.addr.2009.11.025_bib22","unstructured":"http:\/\/www.azonano.com\/oars.asp."},{"key":"10.1016\/j.addr.2009.11.025_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1590\/S0074-02762003000500001","article-title":"Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries","volume":"98","author":"Moncayo","year":"2003","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.025_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1537-2995.2002.00077.x","article-title":"Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission","volume":"42","author":"Leiby","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.addr.2009.11.025_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1086\/590159","article-title":"Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection","volume":"198","author":"Leiby","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.025_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3201\/eid0901.020217","article-title":"Chagas disease in a domestic transmission cycle, southern Texas, USA","volume":"9","author":"Beard","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.025_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1708-8305.2008.00205.x","article-title":"Recognizing and reducing the risks of Chagas disease (American trypanosomiasis) in travellers","volume":"15","author":"Diaz","year":"2008","journal-title":"J. Travel. Med."},{"key":"10.1016\/j.addr.2009.11.025_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3201\/eid1404.070489","article-title":"Chagas disease, France","volume":"14","author":"Lescure","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.025_bib29","article-title":"Chagas Disease: a neglected cardiomyopathy","author":"Rodriguez-Morales","year":"2008","journal-title":"Heart-electronic letters"},{"key":"10.1016\/j.addr.2009.11.025_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijid.2007.12.007","article-title":"Reactivation of Chagas' disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007","volume":"12","author":"Cordova","year":"2008","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.025_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","article-title":"Clinical and epidemiological aspects of Chagas disease","volume":"2","author":"Prata","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.025_bib32","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0968-0896(03)00193-7","article-title":"Synthesis and in vitro trypanocide activity of several polycyclic drimanequinone derivatives","volume":"11","author":"Cuellar","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2009.11.025_bib33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijantimicag.2007.01.014","article-title":"Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas' disease improves cardiopathy","volume":"29","author":"Bustamante","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2009.11.025_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.addr.2009.11.025_bib35","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1128\/AAC.45.4.1210-1215.2001","article-title":"Potent anti-Trypanosma cruzi activities of oxidosqualene cyclase inhibitors","volume":"45","author":"Buckner","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib36","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/jm010459j","article-title":"C. F.E., Synthesis and structure-activity relationship study of potent trypanocidal thiosemicarbazone inhibitors of the trypanosomal cysteine protease cruzain","volume":"45","author":"Du","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2009.11.025_bib37","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/AAC.48.7.2379-2387.2004","article-title":"In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi","volume":"48","author":"Urbina","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib38","unstructured":"http:\/\/www.oneworldhealth.org\/diseases\/chagas.php."},{"key":"10.1016\/j.addr.2009.11.025_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0924-8579(02)00273-X","article-title":"In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease","volume":"21","author":"Urbina","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2009.11.025_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.2007.76.58","article-title":"Lack of efficacy of allopurinol in the human chronic phase of Chagas disease","volume":"76","author":"Rassi","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2009.11.025_bib41","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/00034989957943","article-title":"Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice","volume":"93","author":"Rivarola","year":"1999","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.addr.2009.11.025_bib42","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ijantimicag.2003.10.006","article-title":"Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice","volume":"23","author":"Lo Presti","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2009.11.025_bib43","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1128\/AAC.48.11.4286-4292.2004","article-title":"Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts","volume":"48","author":"Guedes","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib44","unstructured":"J.A. Urbina, Product Development (Preclinical And Clinical) Research Of New Therapeutic Tools For The Specific Treatment Of Chagas Disease, (2005-revisted 2007) 16."},{"key":"10.1016\/j.addr.2009.11.025_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.joms.2009.01.003","article-title":"Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: Clinical findings, assessment of risks, and preventive strategies","volume":"67","author":"Assael","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.addr.2009.11.025_bib46","doi-asserted-by":"crossref","first-page":"28020","DOI":"10.1074\/jbc.272.44.28020","article-title":"In situ compositional analysis of acidocalcisomes in Trypanosoma cruzi","volume":"272","author":"Scott","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2009.11.025_bib47","doi-asserted-by":"crossref","first-page":"22151","DOI":"10.1074\/jbc.273.34.22151","article-title":"Presence of a plant-like proton-pumping pyrophosphatase in acidocalcisomes of Trypanosoma cruzi","volume":"273","author":"Scott","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2009.11.025_bib48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm0002578","article-title":"Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy","volume":"44","author":"Martin","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2009.11.025_bib49","doi-asserted-by":"crossref","first-page":"33609","DOI":"10.1074\/jbc.274.47.33609","article-title":"Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogs","volume":"274","author":"Urbina","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2009.11.025_bib50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijantimicag.2003.07.019","article-title":"Antiparasitic activity of risedronate in a murine model of acute Chagas' disease","volume":"23","author":"Garzoni","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2009.11.025_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00436-005-1331-9","article-title":"Risedronate in the treatment of Murine Chagas' disease","volume":"96","author":"Bouzahzah","year":"2005","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.addr.2009.11.025_bib52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00003088-200544060-00001","article-title":"Pharmacokinetics\/ pharmacodynamics of bisphosphonates: use for optimization of intermittent therapy for osteoporosis","volume":"44","author":"Cremers","year":"2005","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.025_bib53","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.addr.2009.11.025_bib54","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/annonc\/mdj105","article-title":"Management of the adverse effects associated with intravenous bisphosphonates","volume":"17","author":"Tanvetyanon","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2009.11.025_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2009.01.011","article-title":"Bisphosphonates-what the dentist needs to know: Practical considerations","volume":"67","author":"Fantasia","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.addr.2009.11.025_bib56","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0960-894X(01)00057-9","article-title":"Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi","volume":"11","author":"Szajnman","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2009.11.025_bib57","unstructured":"www.fda.gov\/nanotechnology\/faqs.html."},{"key":"10.1016\/j.addr.2009.11.025_bib58","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1289\/ehp.7339","article-title":"Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles","volume":"113","author":"Oberd\u00f6rster","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.addr.2009.11.025_bib59","unstructured":"NIH (National Institutes of Health)\/NCI (National Cancer Institute) Cancer Nanotechnology Plan."},{"key":"10.1016\/j.addr.2009.11.025_bib60","series-title":"Encyclopedia of Molecular Cell Biology and Molecular Medicine","first-page":"163","article-title":"Targeting and intracellular delivery of drugs","author":"Duncan","year":"2005"},{"key":"10.1016\/j.addr.2009.11.025_bib61","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc903","article-title":"Adventures in targeting","volume":"2","author":"Allen","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2009.11.025_bib62","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1471-4892(03)00083-3","article-title":"Antibody-targeted chemotherapy with immunoconjugates of calicheamicin","volume":"3","author":"Damle","year":"2003","journal-title":"Curr. Opin. Phamacol."},{"key":"10.1016\/j.addr.2009.11.025_bib63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrd1413","article-title":"Antibody-targeted radiation cancer therapy","volume":"3","author":"Milenic","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2009.11.025_bib64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2009.11.025_bib65","first-page":"1070","article-title":"Weekly nanoparticle albumin paclitaxel (Abraxane) results in long-term disease control in patients with taxane-refractory metastatic breast cancer","author":"O'Shaughnessy","year":"2004","journal-title":"Proc. San Antonio Breast Cancer Symp."},{"key":"10.1016\/j.addr.2009.11.025_bib66","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer conjugates as anticancer nanomedicines","volume":"6","author":"Duncan","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2009.11.025_bib67","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.bmc.2009.02.043","article-title":"Nanoparticles in cellular drug delivery","volume":"17","author":"Faraji","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2009.11.025_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.05.007","article-title":"Drug delivery systems in HIV pharmacotherapy: What has been done and the challenges standing ahead","volume":"38","author":"Sosnik","year":"2009","journal-title":"J Control. Rel."},{"key":"10.1016\/j.addr.2009.11.025_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijantimicag.2009.02.005","article-title":"Future antibiotics scenarios: is the tide starting to turn?","volume":"34","author":"Theuretzbacher","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2009.11.025_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1083\/jcb.120.1.175","article-title":"Determinants of the translational mobility of a small solute in cell cytoplasm","volume":"120","author":"Kao","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2009.11.025_bib71","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2004.10.004","article-title":"Nuclear delivery of macromolecules: barriers and carriers","volume":"57","author":"Belting","year":"2005","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2009.11.025_bib72","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/jps.21270","article-title":"Nanovehicular intracellular delivery systems","volume":"97","author":"Prokop","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.025_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(01)00152-1","article-title":"Recent advances in the understanding of uptake of microparticles across the gastrointestinal lymphatics","volume":"50","author":"Hussain","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2009.11.025_bib74","first-page":"1145","article-title":"Intestinal Peyer's patch M cells and oral vaccine targeting","volume":"10","author":"Brayden","year":"2005","journal-title":"Drug Del. Tech."},{"key":"10.1016\/j.addr.2009.11.025_bib75","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1023\/A:1026166729873","article-title":"Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity","volume":"20","author":"Jevprasesphant","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.025_bib76","doi-asserted-by":"crossref","first-page":"259-226","DOI":"10.1016\/j.jconrel.2004.03.022","article-title":"Transport of dendrimer nanocarriers through epithelial cells via the transcellular route","volume":"97","author":"Jevprasesphant","year":"2004","journal-title":"J. Controll. Rel."},{"key":"10.1016\/j.addr.2009.11.025_bib77","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2008.09.023","article-title":"Dendrimers as versatile platform in drug delivery applications","volume":"71","author":"Svenson","year":"2009","journal-title":"Eur. J. Pharm. Biopham."},{"key":"10.1016\/j.addr.2009.11.025_bib78","doi-asserted-by":"crossref","first-page":"w315","DOI":"10.1377\/hlthaff.27.4.w315","article-title":"Interview is special FDA regulation of nanomedicine needed?","volume":"27","author":"Alderson","year":"2008","journal-title":"Health Aff."},{"key":"10.1016\/j.addr.2009.11.025_bib79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biopha.2004.01.007","article-title":"Nanomedicines for overcoming biological barriers","volume":"58","author":"Alonso","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2009.11.025_bib80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.addr.2009.11.025_bib81","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.bbamem.2008.07.029","article-title":"pH-sensitive non-phospholipid vesicle and macrophage-like cells: Binding, uptake and endocytotic pathway","volume":"1778","author":"Di Marzio","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2009.11.025_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.proghi.2009.01.001","article-title":"Electron microscopy and cytochemistry analysis of the endocytic pathway of pathogenic protozoa","volume":"44","author":"de Souza","year":"2009","journal-title":"Prog. Histochem. Cytochem."},{"key":"10.1016\/j.addr.2009.11.025_bib83","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/0024-3205(87)90005-1","article-title":"Trypanocidal activity of the stearylamine -bearing liposome","volume":"40","author":"Yoshihara","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2009.11.025_bib84","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1550-7408.1977.tb04762.x","article-title":"Surface charge of Trypanosoma cruzi. Binding of cationized ferritin and measurement of cellular electrophoretic mobility","volume":"24","author":"de Souza","year":"1977","journal-title":"J. Protozool."},{"key":"10.1016\/j.addr.2009.11.025_bib85","first-page":"215","article-title":"Further studies on the cell surface charge of Trypanosoma cruzi","volume":"41","author":"Souto-Padron","year":"1984","journal-title":"Acta Trop."},{"key":"10.1016\/j.addr.2009.11.025_bib86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0014-4894(85)90052-9","article-title":"Trypanosoma cruzi: surface charge and freeze-fracture of amastigotes","volume":"59","author":"de Carvalho","year":"1985","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.addr.2009.11.025_bib87","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.2042-7158.1998.tb03301.x","article-title":"Characterization and trypanocidal activity of nifurtimox-containing and empty nanoparticles of polyethylcyanoacrylates","volume":"50","author":"Gonzalez-Martin","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.025_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4067\/S0716-97602002000100007","article-title":"Cytotoxicity and trypanocidal activity of nifurtimox encapsulated in ethylcyanoacrylate nanoparticles","volume":"35","author":"S\u00e1nchez","year":"2002","journal-title":"Biol. Res."},{"key":"10.1016\/j.addr.2009.11.025_bib89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0939-6411(99)00076-4","article-title":"Allopurinol encapsulated in polycyanoacrylate nanoparticles as potential lysosomatropic carrier: preparation and trypanocidal activity","volume":"49","author":"Gonzalez-Mart\u00edn","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2009.11.025_bib90","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-5173(94)90086-8","article-title":"Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles","volume":"101","author":"Scherer","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.025_bib91","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/app.1966.070100208","article-title":"Synthesis and degradation of poly(alkyl a-cyanoacrylates)","volume":"10","author":"Leonard","year":"1996","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.addr.2009.11.025_bib92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/47.1.101","article-title":"Cure of experimental Chagas\u00b4s disease by the bis-triazole D0870 incorporated into stealth polyethyleneglycol-polylactide nanospheres","volume":"47","author":"Molina","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib93","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.addr.2009.11.025_bib94","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/46.1.137","article-title":"In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi","volume":"46","author":"Molina","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib95","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/158.6.1408","article-title":"Failure of ketoconazole to cure chronic murine Chagas disease","volume":"158","author":"McCabe","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.025_bib96","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0036-46651992000200015","article-title":"Evaluation of the therapeutic activity of itraconazole in chronic infections, experimental and human, by Trypanosoma cruzi","volume":"34","author":"Moreira","year":"1992","journal-title":"Rev. Inst. M\u00e9d. Trop. Sao Paulo"},{"key":"10.1016\/j.addr.2009.11.025_bib97","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1590\/S0074-02761993000100023","article-title":"An experimental and clinical assay with ketoconazole in the treatment of Chagas disease","volume":"88","author":"Brener","year":"1993","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.025_bib98","series-title":"Sterol biosynthesis inhibitors","first-page":"397","article-title":"Pharmacokinetics of azole compounds","author":"Ritter","year":"1988"},{"key":"10.1016\/j.addr.2009.11.025_bib99","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00001432-200112000-00012","article-title":"Specific treatment of Chagas disease: current status and new developments","volume":"14","author":"Urbina","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.025_bib100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1381612023396177","article-title":"Chemotherapy of Chagas disease","volume":"8","author":"Urbina","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2009.11.025_bib101","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/oxfordjournals.jac.a002691","article-title":"Termination of development of D0870","volume":"47","author":"Williams","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib102","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.1999.61.193","article-title":"In vitro and in vivo activity of amphotericin b-lipid formulations against experimental Trypanosoma cruzi infections","volume":"61","author":"Yardley","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2009.11.025_bib103","first-page":"144","article-title":"The effect of amphotericin B on Trypanosoma cruzi in vitro and in vivo","volume":"77","author":"Horvath","year":"1974","journal-title":"J. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2009.11.025_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0001-706X(93)90021-3","article-title":"The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi","volume":"53","author":"de Castro","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.addr.2009.11.025_bib105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(02)00453-2","article-title":"Development and in vitro characterisation of a benznidazole liposomal formulation","volume":"249","author":"Morilla","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.025_bib106","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2004.03.025","article-title":"Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough","volume":"278","author":"Morilla","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.025_bib107","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jconrel.2004.12.012","article-title":"Etanidazole in pH-sensitive liposomes: design, characterization and in vitro\/in vivo anti-Trypanosoma cruzi activity","volume":"103","author":"Morilla","year":"2005","journal-title":"J. Controll. Rel."},{"key":"10.1016\/j.addr.2009.11.025_bib108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0074-02762004000200021","article-title":"In vitro activity of etanidazole against the protozoan parasite Trypanosoma cruzi","volume":"99","author":"Petray","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.025_bib109","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0033-0620(64)80020-7","article-title":"Chagasic myocardiopathy","volume":"7","author":"Rosenbaum","year":"1964","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.addr.2009.11.025_bib110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2741\/1023","article-title":"The significance of autoimmunity in the pathogenesis of Chagas heart disease","volume":"8","author":"Leon","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.addr.2009.11.025_bib111","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0002-9440(10)61741-5","article-title":"Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism","volume":"159","author":"Soares","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2009.11.025_bib112","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1540-8183.2005.04026.x","article-title":"Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of vegf-2 in no-option patients","volume":"18","author":"Reilly","year":"2005","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.addr.2009.11.025_bib113","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/sj.gt.3302740","article-title":"Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy","volume":"13","author":"Azuma","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2009.11.025_bib114","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.athoracsur.2006.03.028","article-title":"Efficacy of therapeutic angiogenesis by intramyocardial injection of pckvegf165 in pigs","volume":"82","author":"Choi","year":"2006","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2009.11.025_bib115","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.addr.2008.03.004","article-title":"Ultrasonic gene and drug delivery to the cardiovascular system","volume":"60","author":"Mayer","year":"2008","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2009.11.025_bib116","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.CIR.98.4.290","article-title":"Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue","volume":"98","author":"Skyba","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2009.11.025_bib117","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/01.CIR.101.22.2554","article-title":"Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium","volume":"101","author":"Shohet","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2009.11.025_bib118","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cardiores.2006.09.021","article-title":"Targeting the heart with gene therapy-optimized gene delivery methods","volume":"73","author":"Muller","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2009.11.025_bib119","first-page":"1","article-title":"The pathology of Chagas' disease (cardiac chronic form)","volume":"6","author":"Andrade","year":"1955","journal-title":"Bol. Fund. G. Moniz"},{"key":"10.1016\/j.addr.2009.11.025_bib120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.CIR.14.6.1035","article-title":"Chagas' disease: a clinical, epidemiologic and pathologic study","volume":"14","author":"Laranja","year":"1956","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2009.11.025_bib121","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0002-9149(88)90148-8","article-title":"Basement membrane thickening in cardiac myocytes and capillaries in chronic Chagas' disease","volume":"61","author":"Ferrans","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.addr.2009.11.025_bib122","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/S0074-02761911000200004","article-title":"Contribui\u00e7\u00e3o para o estudo da anatomia patol\u00f3gica da mol\u00e9stia de Chagas","volume":"3","author":"Vianna","year":"1911","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.025_bib123","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1590\/S0074-02761960000200004","article-title":"Miocit\u00f3lise e fibrose do mioc\u00e1rdio na doen\u00e7a de Chagas","volume":"58","author":"Torres","year":"1960","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.025_bib124","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/01.CIR.82.6.1900","article-title":"Pathophysiological insights into the cardiomyopathy of Chagas' disease","volume":"82","author":"Morris","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2009.11.025_bib125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-8703(90)90191-Y","article-title":"Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease","volume":"120","author":"Rossi","year":"1990","journal-title":"Am. Heart J."},{"key":"10.1016\/j.addr.2009.11.025_bib126","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of Chronic Chagas Heart Disease","volume":"115","author":"Marin-Neto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2009.11.025_bib127","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1590\/S1516-31801995000200014","article-title":"Studies of the coronary circulation in Chagas' heart disease","volume":"113","author":"Marin-Neto","year":"1995","journal-title":"S\u00e3o Paulo Med. J."},{"key":"10.1016\/j.addr.2009.11.025_bib128","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1369\/jhc.5A6654.2005","article-title":"Trypanosoma cruzi modulates the expression of rabs and alters the endocytosis in mouse cardiomyocytes in vitro","volume":"54","author":"Batista","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.addr.2009.11.025_bib129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pbiomolbio.2009.01.012","article-title":"Caveolae, ion channels and cardiac arrhythmias","volume":"98","author":"Balijepalli","year":"2008","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.addr.2009.11.025_bib130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nbt1292","article-title":"Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung","volume":"25","author":"Oh","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2009.11.025_bib131","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1021\/bm049936g","article-title":"Understanding the mechanism of action of poly(amidoamine)s as endosomolytic polymers: correlation of physicochemical and biological properties","volume":"5","author":"Griffiths","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2009.11.025_bib132","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/10611860400011885","article-title":"Polyacetal-diethylstilboestrol: a polymeric drug designed for pH-triggered activation","volume":"12","author":"Vicent","year":"2004","journal-title":"J. Drug Targeting"},{"key":"10.1016\/j.addr.2009.11.025_bib133","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nnano.2007.433","article-title":"Sizing up targets with nanoparticles","volume":"3","author":"Minchin","year":"2008","journal-title":"Nature Nanotechnology"},{"key":"10.1016\/j.addr.2009.11.025_bib134","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0939-6411(02)00062-0","article-title":"Liposomes produced in a pilot scale: production, purification and efficiency aspects","volume":"54","author":"Wagner","year":"2002","journal-title":"Eur. J. Pharm. Biopham."},{"key":"10.1016\/j.addr.2009.11.025_bib135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/toxsci\/kfl165","article-title":"Pounds particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments","volume":"95","author":"Teeguarden","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.addr.2009.11.025_bib136","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","article-title":"Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsable for rapid elimination of a second dose of PEGylated liposomes","volume":"112","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2009.11.025_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.06.009","article-title":"Pharmaceutical nanotechnology: More than size. Ten topics for research","volume":"339","author":"Florence","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.025_bib138","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/000349803125002751","article-title":"Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up","volume":"97","author":"Apt","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.addr.2009.11.025_bib139","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.44.1.150-155.2000","article-title":"Activities of the triazole derivative SCH 56592 (Posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts","volume":"44","author":"Molina","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib140","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1126\/science.273.5277.969","article-title":"Cure of short- and long-term experimental Chagas disease using D0870","volume":"273","author":"Urbina","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.addr.2009.11.025_bib141","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/AAC.44.9.2498-2502.2000","article-title":"In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi","volume":"44","author":"Urbina","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib142","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(02)00274-1","article-title":"Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains","volume":"21","author":"Urbina","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2009.11.025_bib143","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.49.4.1556-1560.2005","article-title":"Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease","volume":"49","author":"Corrales","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.025_bib144","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0002-8703(83)90022-4","article-title":"Ten years of experience with amiodarone","volume":"106","author":"Rosenbaum","year":"1983","journal-title":"Am. Heart J."},{"key":"10.1016\/j.addr.2009.11.025_bib145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/clc.4960231205","article-title":"Chagas' heart disease","volume":"23","author":"Rassi","year":"2000","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.addr.2009.11.025_bib146","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.188.4.725","article-title":"Cysteine protease inhibitors cure experimental Trypanosoma cruzi infection","volume":"188","author":"Engel","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2009.11.025_bib147","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijantimicag.2003.07.020","article-title":"Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi","volume":"23","author":"Garzoni","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2009.11.025_bib148","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568005013343191","article-title":"Bisphosphonates as chemotherapeutic agents against Trypanosomatid and Apicomplexan parasites","volume":"1","author":"Docampo","year":"2001","journal-title":"Curr. Drug Target Infec. Disord."},{"key":"10.1016\/j.addr.2009.11.025_bib149","first-page":"147","article-title":"Quimioterapia de la Enfermedad de Chagas","volume":"59","author":"Stoppani","year":"1999","journal-title":"Medicina"},{"key":"10.1016\/j.addr.2009.11.025_bib150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0037-86821988000200011","article-title":"Ineffectiveness of allopurinol in patients in the acute phase Chagas of Chagas disease","volume":"21","author":"Lauria-Pires","year":"1988","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.addr.2009.11.025_bib151","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.2007.76.58","article-title":"A., G.G. Rassi, S.G. Rassi, D.A.S. IG, A.G. Rassi, Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease","volume":"76","author":"Rassi","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2009.11.025_bib152","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.1998.59.133","article-title":"Treatment of chronic Chagas' disease with itraconazole and allopurinol","volume":"59","author":"Apt","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X09003664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X09003664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T21:09:56Z","timestamp":1558645796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X09003664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":152,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0169409X09003664"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2009.11.025","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}